Cost-effectiveness of in vitro fertilization

Area of Science:

• Reproductive Medicine
• Health Economics

Background:

• In vitro fertilization (IVF) is a crucial treatment for infertility.
• Despite its effectiveness, IVF remains underutilized globally.
• High costs and low patient uptake present significant barriers to IVF accessibility.

Purpose of the Study:

• To analyze the cost-effectiveness and international pricing of IVF.
• To investigate factors influencing IVF treatment uptake.
• To provide insights into optimizing IVF accessibility and utilization.

Main Methods:

• Comparative analysis of projected IVF cycle and delivery costs in the US versus other countries.
• Review of existing randomized controlled trials on IVF cost-effectiveness.
• Examination of the impact of multiple gestation births on overall IVF treatment costs.

Main Results:

• Projected median IVF cycle costs in 2001 were $9226 in the US and $3531 internationally.
• Projected cost per delivery via IVF in 2001 averaged $56,419 in the US and $20,522 internationally.
• Multiple gestation births increased IVF cycle costs by 36%, significantly impacting overall expenses.
• Current IVF uptake falls below the estimated need of 1500 cycles per million population annually.

Conclusions:

• IVF cost-effectiveness requires further robust evidence, despite challenges in trial design.
• Reducing IVF treatment prices is likely to increase patient uptake among infertile populations.
• Addressing cost barriers and optimizing treatment protocols are essential for improving global access to IVF services.